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SUMMARY 
 
It is known that the brain can be affected by many diseases/disorders for which 
therapies are not yet available.   Recently, different investigators have reported on the ability 
of stem cells to differentiate into different neural cell types in vitro and in vivo. This 
knowledge opened new perspectives in stem cell therapy for neurological disorders/diseases.   
Hematopoietic (HSC), mesenchymal (MSC) and neural (NSC) stem cells are the most 
promising source of stem cells given either their easiness of harvest or their differentiative 
ability. Upon grafting into the brain, stem cells could give rise directly to new neurons or 
could generate other cells of the central nervous system, such oligodendrocytes, or glial cells, 
that may contribute to neural growth. Furthermore these cells could be therapeutic by 
secreting missing substances or enzymes that are needed for the normal function of the brain. 
Since mesenchymal stem cells (MSCs) have been shown to suppress T-cell activation in vitro 
and in vivo, transplantation of these cells into the brain could led not only to a source of new 
neural cells but also could provide an anti-inflammatory response.   In order to investigate the 
therapeutic potential of different sources of stem cells, pre-immune fetal sheep were 
transplanted by intraperitoneal injection, at 60 days of gestation, with HSC, NSC or MSC.  
Animals were euthanized at 60-80 days post transplantation and tissues were collected from 
different regions of the brain and analyzed by flow cytometry and immunohistochemistry 
using different antibodies for known neural markers.  Levels of donor cell engraftment and 
types of neural cells obtained were then correlated to the source of the transplanted cells.   We 
hope that these studies will be able to discern what is/are the best source(s) of stem cells to 
use for neural cell replacement therapies. 
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